NASDAQ:IVF INVO Fertility (IVF) Stock Price, News & Analysis $0.96 +0.01 (+0.88%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About INVO Fertility Stock (NASDAQ:IVF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get INVO Fertility alerts:Sign Up Key Stats Today's Range$0.93▼$0.9950-Day Range$0.95▼$3.6652-Week Range$0.93▼$51.12Volume170,927 shsAverage Volume975,664 shsMarket Capitalization$4.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida. Read More Receive IVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Fertility and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IVF Stock News HeadlinesINVO Fertility Amends Financial Agreement with Five Narrow LaneAugust 22, 2025 | tipranks.comINVO Fertility (NASDAQ:IVF) Trading Down 22% - Here's WhyAugust 20, 2025 | americanbankingnews.comThis stock could leave NVDA in the dustInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.August 29 at 2:00 AM | InvestorPlace (Ad)INVO Fertility, Inc.: INVO Fertility Announces Second Quarter 2025 Financial ResultsAugust 15, 2025 | finanznachrichten.deINVO Fertility Announces Second Quarter 2025 Financial ResultsAugust 14, 2025 | globenewswire.comINVO Fertility’s Recent Unregistered Equity SaleAugust 9, 2025 | theglobeandmail.comINVO Fertility Implements Reverse Stock SplitJuly 24, 2025 | theglobeandmail.comINVO Fertility Announces First Quarter 2025 Financial ResultsMay 20, 2025 | globenewswire.comSee More Headlines IVF Stock Analysis - Frequently Asked Questions How have IVF shares performed this year? INVO Fertility's stock was trading at $29.16 at the start of the year. Since then, IVF stock has decreased by 96.7% and is now trading at $0.9599. How were INVO Fertility's earnings last quarter? INVO Fertility, Inc (NASDAQ:IVF) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($7.95) EPS for the quarter. The company had revenue of $1.86 million for the quarter. When did INVO Fertility's stock split? INVO Fertility's stock reverse split before market open on Monday, July 21st 2025.The 1-3 reverse split was announced on Monday, July 21st 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. How do I buy shares of INVO Fertility? Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2025Today8/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:IVF Previous SymbolNASDAQ:INVO CIK1417926 Webwww.invobioscience.com Phone(978) 878-9505FaxN/AEmployees25Year FoundedN/AProfitability EPS (Trailing Twelve Months)($93.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.10 million Net Margins-422.11% Pretax Margin-391.12% Return on EquityN/A Return on Assets-90.34% Debt Debt-to-Equity RatioN/A Current Ratio0.11 Quick Ratio0.10 Sales & Book Value Annual Sales$6.53 million Price / Sales0.64 Cash FlowN/A Price / Cash FlowN/A Book Value($1.72) per share Price / Book-0.55Miscellaneous Outstanding Shares4,360,000Free Float4,338,000Market Cap$4.16 million OptionableNo Data Beta1.99 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:IVF) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access